Vista Exclusive Content
Breast Cancer Innovator Atossa Genetics Adds Former Pfizer & Boehringer Ingelheim Execs To New Strategic Advisory Board
Seattle based Atossa Genetics Inc. (ATOS) is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. Today Atossa announced the formation of a strategic advisory board (SAB) comprised of prominent executives from the pharmaceutical industry. The
Merck Surpasses Q1 Earnings Estimates
Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some the of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue
Shares of Atossa Genetics Jump Post Mammographic Breast Density Phase 2 Trial Announcement
Seattle based Atossa Genetics Inc. (ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, saw their shares jump significantly today hitting an intraday high of $4.59/share & then closed up +29.97% at $4.38/share on ~4,150,000
Company News Around The Web
20 May 2018 | 11:42 am
Congo to begin Ebola vaccinations on Monday...
Health workers in Democratic Republic of Congo will begin a ...
18 May 2018 | 6:58 pm
Eli Lilly’s Valuation on May 17
Eli Lilly (LLY) reported EPS of $1.34 and revenues of $5.7 b...
18 May 2018 | 3:13 pm
3 Dow Stocks to Buy With Dividends...
These well-known companies will deliver the dividend income ...
18 May 2018 | 10:00 am
Why J&J's Stock May Plunge 10%
Johnson & Johnson ( JNJ) shares may drop by about 10% ba...
17 May 2018 | 3:27 pm
Investors Need to Adopt a Different Mindset...
The ability to sell new drugs hinges on approvals from gover...
17 May 2018 | 2:31 pm
Taking Stock of Gilead Sciences’ Key Developments
During the first quarter, Gilead Sciences (GILD) entered int...
|Day Low - High||-|
|Year Low - High||-|